Myriad Genetics (MYGN) Other Working Capital Changes (2016 - 2026)
Myriad Genetics has reported Other Working Capital Changes over the past 17 years, most recently at -$1.8 million for Q4 2025.
- Quarterly Other Working Capital Changes fell 700.0% to -$1.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$200000.0 through Dec 2025, down 113.33% year-over-year, with the annual reading at -$200000.0 for FY2025, 113.33% down from the prior year.
- Other Working Capital Changes was -$1.8 million for Q4 2025 at Myriad Genetics, down from $1.9 million in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $4.7 million in Q3 2022 and troughed at -$24.8 million in Q3 2021.
- The 5-year median for Other Working Capital Changes is $550000.0 (2023), against an average of -$1.1 million.
- The largest YoY upside for Other Working Capital Changes was 1150.0% in 2021 against a maximum downside of 4033.33% in 2021.
- A 5-year view of Other Working Capital Changes shows it stood at -$6.2 million in 2021, then surged by 35.48% to -$4.0 million in 2022, then skyrocketed by 165.0% to $2.6 million in 2023, then tumbled by 88.46% to $300000.0 in 2024, then plummeted by 700.0% to -$1.8 million in 2025.
- Per Business Quant, the three most recent readings for MYGN's Other Working Capital Changes are -$1.8 million (Q4 2025), $1.9 million (Q3 2025), and -$2.5 million (Q2 2025).